Page All:
Page 1
Algerian Ministry of Higher Education & Research Chooses Elsevier Solutions to Pursue National Research Goals
ALGIERS, Algeria, November 2, 2011/PRNewswire-FirstCall/ --
National agreement result of intensive cooperation on defining
research community needs
The Ministry of Higher Education & Research of Algeria has chosen
Elsevier, the world-leading provider of scientific, technical and medical
information products and services, as its main provider of services to help
the nation achieve research excellence. The ministry signed multi-year
agreements for access to SciVerse ScienceDirect, SciVerse Scopus, Reaxys(R)
and intermediate backfiles.
Algeria aims to play a leading role in fields of research in which the
country already performs strongly: chemistry, chemical engineering, material
sciences and pharmacology. These multi-year agreements with Elsevier will
support this journey. The agreements involve providing access to full text
articles on SciVerse ScienceDirect and to intermediate back files for more
than 50 universities and research institutes, and access to SciVerse Scopus,
the world's largest abstract and citation database for six of the biggest
Algerian universities. To support its ambitions in the field of chemistry,
the ministry chose to work with Reaxys [https://www.reaxys.com/info ], the
web-based chemistry workflow solution which supports research and fuels
discovery.
Professor Hafid Aourag, Director General of Scientific Research of the
Ministry of Higher Education, said, "Elsevier has provided us with an
extremely valuable source of full text articles, abstracts and citation
data, as well as innovative solutions to support Algeria's strategic
research objectives. We are confident that these sources and solutions will
help us enhance our country's research performance."
Said Taha, Regional Director MEA, Turkey and Central Asia at Elsevier,
said, "It has been a pleasure to work together with the ministry over the
past months, defining the true needs within the scientific community of
Algeria. We are proud to be playing an important role in the research
ambitions of an entire nation."
About the Algerian Ministry of Higher Education & Research
The Ministry of Higher Education and Scientific Research is the
department responsible for the development and the progress of the academic
sector and scientific research in Algeria. To achieve these objectives, the
ministry has created two institutions: The Research Centre on Scientific and
Technical Information (CERIST) was founded in 1985 with the primary
objective to implement programs of scientific research and technological
development in the field of information science and technology. The General
Directorate for Scientific Research and Technological Development (DG-RSDT)
came into being in September 2009, and was set up by law # 08-05 of February
23, 2008, which defines the five-years scientific national research plan
(2008-2012), expected to move the Algerian research system to excellency for
a sustainable development. By this law, the DG-RSDT is the principal enabler
of national scientific research and development.
About the Elsevier SciVerse Suite
The SciVerse ( http://www.sciverse.com) suite of search and
discovery offerings provides the global research community access to a
constantly expanding universe of content and solutions which can now be
accessed in one platform. The suite currently includes SciVerse
ScienceDirect ( http://www.sciencedirect.com), the world's largest
source of peer-reviewed content containing more than 10 million articles,
and SciVerse Scopus ( http://www.scopus.com), an abstract and citation
database containing 41 million records, 70% with abstracts and nearly 18,000
titles from 5,000 publishers worldwide. The platform also includes SciVerse
Hub beta ( http://www.hub.sciverse.com), which enables researchers to
perform a single search across all of the SciVerse content as well as
targeted web content with results ranked by relevancy and without
duplication. SciVerse Applications (
http://www.applications.sciverse.com) and Developer Network (
http://www.developers.sciverse.com) allow the scientific community to
build, find and use applications that enhance the SciVerse research
experience.
About Reaxys
Reaxys is a workflow solution for research chemists that provides
extensive information on chemical compounds, related physical and
pharmacological properties, and synthesis information. Researchers can get
the experimentally validated information they need in a single overview,
from source publications carefully selected for their importance and
relevance to research chemists. Elsevier continues to engage with the
chemistry community to ensure that Reaxys continues to reflect how chemists
think and work. For more information please visit reaxys.com/info
[http://www.reaxys.com/info ].
Reaxys(R) and the Reaxys(R) trademark are owned and protected by
Elsevier Properties SA. All rights reserved
About Elsevier
Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai's Pinpoint Review [http://www.medai.com ], which help research and
health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier
[http://www.elsevier.com ] employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).
Media contact
Harald Boersma
Senior Manager Corporate Relations, Elsevier
+31-20-485-27-36
h.boersma@elsevier.com
Source: Elsevier
.
Algerian Ministry of Higher Education & Research Chooses Elsevier Solutions to Pursue National Research Goals
ALGIERS, Algeria, November 2, 2011/PRNewswire-FirstCall/ --
National agreement result of intensive cooperation on defining
research community needs
The Ministry of Higher Education & Research of Algeria has chosen
Elsevier, the world-leading provider of scientific, technical and medical
information products and services, as its main provider of services to help
the nation achieve research excellence. The ministry signed multi-year
agreements for access to SciVerse ScienceDirect, SciVerse Scopus, Reaxys(R)
and intermediate backfiles.
Algeria aims to play a leading role in fields of research in which the
country already performs strongly: chemistry, chemical engineering, material
sciences and pharmacology. These multi-year agreements with Elsevier will
support this journey. The agreements involve providing access to full text
articles on SciVerse ScienceDirect and to intermediate back files for more
than 50 universities and research institutes, and access to SciVerse Scopus,
the world's largest abstract and citation database for six of the biggest
Algerian universities. To support its ambitions in the field of chemistry,
the ministry chose to work with Reaxys [https://www.reaxys.com/info ], the
web-based chemistry workflow solution which supports research and fuels
discovery.
Professor Hafid Aourag, Director General of Scientific Research of the
Ministry of Higher Education, said, "Elsevier has provided us with an
extremely valuable source of full text articles, abstracts and citation
data, as well as innovative solutions to support Algeria's strategic
research objectives. We are confident that these sources and solutions will
help us enhance our country's research performance."
Said Taha, Regional Director MEA, Turkey and Central Asia at Elsevier,
said, "It has been a pleasure to work together with the ministry over the
past months, defining the true needs within the scientific community of
Algeria. We are proud to be playing an important role in the research
ambitions of an entire nation."
About the Algerian Ministry of Higher Education & Research
The Ministry of Higher Education and Scientific Research is the
department responsible for the development and the progress of the academic
sector and scientific research in Algeria. To achieve these objectives, the
ministry has created two institutions: The Research Centre on Scientific and
Technical Information (CERIST) was founded in 1985 with the primary
objective to implement programs of scientific research and technological
development in the field of information science and technology. The General
Directorate for Scientific Research and Technological Development (DG-RSDT)
came into being in September 2009, and was set up by law # 08-05 of February
23, 2008, which defines the five-years scientific national research plan
(2008-2012), expected to move the Algerian research system to excellency for
a sustainable development. By this law, the DG-RSDT is the principal enabler
of national scientific research and development.
About the Elsevier SciVerse Suite
The SciVerse ( http://www.sciverse.com) suite of search and
discovery offerings provides the global research community access to a
constantly expanding universe of content and solutions which can now be
accessed in one platform. The suite currently includes SciVerse
ScienceDirect ( http://www.sciencedirect.com), the world's largest
source of peer-reviewed content containing more than 10 million articles,
and SciVerse Scopus ( http://www.scopus.com), an abstract and citation
database containing 41 million records, 70% with abstracts and nearly 18,000
titles from 5,000 publishers worldwide. The platform also includes SciVerse
Hub beta ( http://www.hub.sciverse.com), which enables researchers to
perform a single search across all of the SciVerse content as well as
targeted web content with results ranked by relevancy and without
duplication. SciVerse Applications (
http://www.applications.sciverse.com) and Developer Network (
http://www.developers.sciverse.com) allow the scientific community to
build, find and use applications that enhance the SciVerse research
experience.
About Reaxys
Reaxys is a workflow solution for research chemists that provides
extensive information on chemical compounds, related physical and
pharmacological properties, and synthesis information. Researchers can get
the experimentally validated information they need in a single overview,
from source publications carefully selected for their importance and
relevance to research chemists. Elsevier continues to engage with the
chemistry community to ensure that Reaxys continues to reflect how chemists
think and work. For more information please visit reaxys.com/info
[http://www.reaxys.com/info ].
Reaxys(R) and the Reaxys(R) trademark are owned and protected by
Elsevier Properties SA. All rights reserved
About Elsevier
Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai's Pinpoint Review [http://www.medai.com ], which help research and
health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier
[http://www.elsevier.com ] employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).
Media contact
Harald Boersma
Senior Manager Corporate Relations, Elsevier
+31-20-485-27-36
h.boersma@elsevier.com
Source: Elsevier
.